Trevi Therapeutics competitorsClear all

Trevi Therapeutics's top competitors include Ncardia, Hepion Pharmaceuticals, Rigel Pharmaceuticals and Constellation Pharmaceuticals.
Trevi Therapeutics
Trevi Therapeutics
Trevi Therapeutics is a drug development company.
Ncardia
Ncardia
Ncardia is a stem cell drug discovery and development company.
Hepion Pharmaceuticals
Hepion Pharmaceuticals
Hepion Pharmaceuticals (formerly known as ContraVir Pharmaceuticals) is a clinical-stage biopharmaceutical company focused on the development of targeted therapies for liver disease.
Rigel Pharmaceuticals
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Constellation Pharmaceuticals
Constellation Pharmaceuticals
Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers and develops novel therapeutics that address serious unmet medical needs in patients with cancers.
Founding Date
Founding Date
2011
Founding Date
2010
Founding Date
2013
Founding Date
1996
Founding Date
2008
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New Haven, US HQ
Locations
Gosselies, BE HQ
Leiden, NL
Locations
Edison, US HQ
Edmonton, CA
Locations
South San Francisco, US HQ
Locations
Cambridge, US HQ
Employees
Employees
1912% increase
Employees
562% decrease
Employees
1430% decrease
Employees
1633% increase
Employees
8228% increase
Valuation ($)
Valuation ($)
71.5 m
Valuation ($)
N/A
Valuation ($)
26.3 m
Valuation ($)
383.5 m
Valuation ($)
837 m
Twitter followers
Twitter followers
125
Twitter followers
883
Twitter followers
172
Twitter followers
1.8 k
Twitter followers
999
Number of tweets (last 30 days)
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
14
Number of tweets (last 30 days)
9
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2
Average likes per tweet (last 30 days)
3.4
Average likes per tweet (last 30 days)
0.6
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
85.71%
Percentage of tweets with engagement (last 30 days)
55.56%
Alexa Website Rank
Alexa Website Rank
473824
Alexa Website Rank
444827
Alexa Website Rank
297805
Alexa Website Rank
251438
Alexa Website Rank
383472
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.3
Employee Rating
4

Financial

Net income
Net income
($26.1m) (FY, 2019)
Net income
N/A
Net income
($6.7m) (FY, 2019)
Net income
($66.9m) (FY, 2019)
Net income
($35.4m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 94.1m
Total funding raised
$ 20.2m
Total funding raised
$ 16.9m
Total funding raised
$ 130m
Total funding raised
$ 403.6m
For sources of this data, please see the company profile

View company profiles

Ncardia
HQ
Gosselies, BE
Employees
56↓ 2% decrease

Ncardia is a stem cell drug discovery and development company.

View company
Hepion Pharmaceuticals
HQ
Edison, US
Employees
14↓ 30% decrease

Hepion Pharmaceuticals (formerly known as ContraVir Pharmaceuticals) is a clinical-stage biopharmaceutical company focused on the development of targeted therapies for liver disease.

View company
Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
163↑ 3% increase

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.

View company
Constellation Pharmaceuticals
HQ
Cambridge, US
Employees
82↑ 28% increase

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers and develops novel therapeutics that address serious unmet medical needs in patients with cancers.

View company